Platelet-rich plasma versus hyaluronic acid injections for knee osteoarthritis
Compares platelet-rich plasma with hyaluronic acid injections in adults with knee osteoarthritis.
Key facts
- Who runs it
- Endeavor Health
- Where
- Skokie, United StatesSee the site
- Trial code
- Registry title
- Intra-articular Platelet-Rich Plasma Compared With Viscosupplementation in the Treatment of Knee Osteoarthritis
- Status
- Recruiting
- Phase
- Phase 2
- People taking part
- 100 people, planned
- Started
- 13 Jun 2018
- Expected to end
- Dec 2027
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- PRP Treatment
- HA Treatment
- Record updated
- 28 February 2024
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with long-lasting knee pain from knee osteoarthritis (wear of the knee joint). It compares platelet-rich plasma (PRP) injections with hyaluronic acid (HA) injections.
- Age
- 18 to 75 years
- Sex
- All sexes
- Disease stage
- Knee osteoarthritis grade 2-3 on the Kellgren-Lawrence X-ray scale. Pain for more than 3 months, with a pain score of at least 40 out of 100.
- Earlier treatment
- No HA or PRP injection into the affected knee in the last two years. No knee surgery in the 12 months before treatment. No joint injection treatment in the 3 weeks before treatment.
- Biomarker or test result
- Blood count, CRP and ESR (inflammation blood tests) must be within normal limits. Cannot join with hemoglobin <12 g/dL or platelets <150,000 /mm3.
Main reasons for not taking part
- Major bending of the leg axis (>5° valgus or varus)
- Autoimmune disease, immune suppression, active infection or diabetes
- Blood thinner therapy or active cancer treatment
- Pregnancy or breastfeeding
- Cannot have an MRI because of metal implants or fear of closed spaces
The registry criteria, word for word
Show all 30 criteriaShow less
Who can take part
- Ability to provide informed consent
- Chronic pain (>3 months)
- Grade 2 -3 according to Kellgren- Lawrence (K-L) classification system (using bilateral anteroposterior radiograph image acquired while the patient is weight-bearing with both knees in full extension)
- Minimum score of 40 out of possible 100 on the VAS (Visual Analog Scale) for pain
- Age 18 to 75 years old
- Physical exam and medical history
- Complete Blood Count to include platelets and differential (CBC with Diff) within normal limits
- C-Reactive Protein (CRP) within normal limits
- Sed Rate (ESR) within normal limits
- Survey of current medications
Who cannot take part
- Surgery on target knee within 12 months prior to scheduled treatment
- Anti-coagulant therapy
- Use of NSAIDs 5 days prior to blood draw or up to 7 days after last PRP / HA treatment
- Previous infiltrative treatment within 3 weeks prior to scheduled treatment
- Inability to complete an MRI due to metal implants or claustrophobia
- Autoimmune disorder
- Active infections
- Hypersensitivity to HA
- Diabetes
- Active treatment for a malignancy
- Recent history of knee trauma
- Hemoglobin (Hg) <12 g/dL
- Platelet counts (PLT) <150,000 /mm3
- An injection of hyaluronic acid (HA) or platelet-rich plasma (PRP) to the affected knee within the last two years
- Presence of major axial deformity (>5° valgus or varus deviation)
- Immuno-suppression (e.g., AIDS, etc.)
- Pregnancy/Breastfeeding
- Active wound in the knee
- Vasovagal history
- In the judgment of the investigator, the patient is unable to perform and/or complete all of the study visits or treatments required
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 75 years old?
Where in United States
- NorthShore University HealthSystemsSkokie, United StatesContact: Jason L Koh, MD, MBATaking people
About the trial
What the trial wants to find out
This is a single-center, prospective, randomized, single-blind, comparator therapy, parallel group study for symptomatic patients diagnosed with knee osteoarthritis. The aim is to demonstrate superior efficacy of platelet-rich plasma (PRP) as compared to hyaluronic acid (HA) in treating knee osteoarthritis. This aim will be objectively measured by endpoint consisting of changes in cartilage thickness from baseline in the MRI. The Knee Injury and Osteoarthritis Outcome Score (KOOS) Questionnaire will be used to calculate The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) total score. It will measure changes in pain and function from baseline. Approximately 100 subjects will be treated at NorthShore University HealthSystem (NorthShore) as part of this study. This study has the potential to improve outcomes in a very common chronic degenerative disease, osteoarthritis, which can have a significant effect on individuals' quality of life.
The 2 groups in the trial
- PRP TreatmentTreatment being tested
PRP is injected using 22 gauge needles through the classic approach (lateral midpatellar) in a sterile setting. The PRP is obtained from a maximum 16 cc sample of the patients' blood drawn at the time of treatment. Using sterile technique, the venous blood is transferred to a centrifuge and prepared by the centrifugation process for 5 minutes. 4-7 mL of PRP is transferred from the large outer syringe into the small inner syringe and injected within 30 minutes of being spun to negate the need of anticoagulants. The procedure will take approximately 20-30 minutes.
- HA TreatmentExisting treatment, for comparison
HA is injected using 22 gauge needles through the classic approach (lateral midpatellar) in a sterile setting. Euflexxa will be prepared according to the package insert.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Does Intra-articular Platelet-Rich Plasma Injection Provide Superior Outcomes Compared With Viscosupplementation in the Treatment of Knee Osteoarthritis?
- Plain-language title
- Platelet-rich plasma versus hyaluronic acid injections for knee osteoarthritisGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Fit questions
- Built from NCT03491761, who can take part
- Record updated
- 28 February 2024